In this issue:
Long-term outcomes of LyMa-101 trial
Final analysis of CLL2-BAAG study
Clinical benefits of CRh
PD-1 blockade for HIV-cHL patients
Impact of tocilizumab on CAR T-cell therapy
Synergistic effects of radiotherapy on CAR T therapy
CAR T-cell therapy and bispecific antibodies
Clinical and prognostic value of ctDNA
Induced chemotherapy versus HMA/VEN
Efficacy and safety of ibrutinib
Please login below to download this issue (PDF)